SecBot SecBot
SECBOTREPLAY Home › Report › TYRA

TYRA · Nextech VI Oncology SCSP, a significant VC shareholder, filed a Form…

Tyra Biosciences, Inc. · 144 filed Jun 26, 2026 at 16:59 ET

At the news

BEARISHIMPACT 6/10

144 filed Jun 26, 2026 at 16:59 ET

Nextech VI Oncology SCSP, a significant VC shareholder, filed a Form 144 to sell 308,379 shares (~$9.5M) after already selling ~129k shares (~$4M) in the prior week. This signals near-term profit-taking and creates overhang, potentially weighing on TYRA shares despite strong fundamentals.

  • Nextech VI Oncology SCSP plans to sell 308,379 common shares, valued at ~$9.5M.
  • Same entity sold 128,949 shares (~$4.0M) in the week prior (June 1, 23-25, 2026).
  • Proposed sale is ~0.58% of TYRA's $1.8B market cap; combined recent+proposed is ~0.75%.
  • Shares were acquired in a private placement on Sep 17, 2021, now being steadily sold.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access